"65862-313-05" National Drug Code (NDC)

Didanosine 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-313-05)
(Aurobindo Pharma Limited)

NDC Code65862-313-05
Package Description500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-313-05)
Product NDC65862-313
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameDidanosine
Non-Proprietary NameDidanosine
Dosage FormCAPSULE, DELAYED RELEASE
UsageORAL
Start Marketing Date20080924
Marketing Category NameANDA
Application NumberANDA090094
ManufacturerAurobindo Pharma Limited
Substance NameDIDANOSINE
Strength400
Strength Unitmg/1
Pharmacy ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/65862-313-05